Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Duobrii for plaque psoriasis

April 26, 2019

University of Miami presents new compositions for epidermolysis bullosa

April 26, 2019

Structure, activity described for AMG-510, the first-in-human covalent inhibitor of KRAS G12C

April 26, 2019

Takeda identifies glutamate receptor agonists

April 26, 2019

hSTING modulators disclosed in GlaxoSmithKline patent

April 26, 2019

Takeda presents JAK inhibitors

April 26, 2019

GlaxoSmithKline patents new HBV inhibitors

April 26, 2019

OMPTA agent POL-7306 is potent against Gram-negative bacteria in vitro and in vivo

April 26, 2019

DOC2A Ca2+ sensor is overexpressed in temporal lobe epilepsy in humans and rat models

April 26, 2019

Kezar Life Sciences presents new compounds with antitumoral activity

April 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...